Comparing effectiveness of local steroid injection into carpal tunnel with surgery in the treatment of patients with mild to moderate carpal tunnel syndrome

Comparing effectiveness of Local steroid injection versus CTR in the treatment of patients with mild to moderate CTS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011832046N1

Enrollment

Registered

2017-07-06

Start date

2005-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Injection of 40 mg triamcinolone with 20 gm lidocaine into the carpal tunnel in intervention group. Intervention 2: Carpal tunnel release in control group.

Treatment - Drugs

Treatment - Surgery

Injection of 40 mg triamcinolone with 20 gm lidocaine into the carpal tunnel in intervention group.

Carpal tunnel release in control group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Every patient with CTS. Exclusion criteria: Any patient with CTS having underlying diseases such as diabetes, thyroid diseases,previous wrist fx,ganglion cyst, etc.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Tingling, numbness, pain, atrophy. Timepoint: Before treatment and 6 month afer treatment. Method of measurement: Boston questienare.;Severity of symptoms and patients satisfaction. Timepoint: Before and 6 month after treatment. Method of measurement: ElMG and NCV findings and patient satisfaction questionaire.;Physical signs such as Tinnel, compresion test, thenar atrophy and Phallen test. Timepoint: Before intervention and six month after it. Method of measurement: Physical examination tests were done according to rules in references.	—

Measure

Time frame

Tingling, numbness, pain, atrophy. Timepoint: Before treatment and 6 month afer treatment. Method of measurement: Boston questienare.;Severity of symptoms and patients satisfaction. Timepoint: Before and 6 month after treatment. Method of measurement: ElMG and NCV findings and patient satisfaction questionaire.;Physical signs such as Tinnel, compresion test, thenar atrophy and Phallen test. Timepoint: Before intervention and six month after it. Method of measurement: Physical examination tests were done according to rules in references.

—

Secondary

Measure	Time frame
Pain and sudeck atrophy. Timepoint: Six month after intervention. Method of measurement: Physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabaei Reza

ShafaYahyaiian Hospital

Babaei.reza52@gmail.com+98 21 3354 2011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026